eIF3 η Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF3 η monoclonal antibodies for investigating the role of this essential protein in cellular processes. eIF3 η Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF3 η is a critical component of the eukaryotic translation initiation factor 3 (eIF3) complex, which plays a vital role in the regulation of protein synthesis. By facilitating the recruitment of mRNA and the ribosomal subunit, eIF3 η is integral to the initiation of translation, influencing cell growth and proliferation. Understanding eIF3 η function is essential for elucidating mechanisms of gene expression and the impact of dysregulation in various diseases. Research applications include studying translation initiation mechanisms, cellular growth regulation, and disease pathways. Investigating eIF3 η can provide valuable insights into cancer development and potential therapeutic targets. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cellular translation processes.